Therapeutische erfahrungen mit pangramin-SLIT im vergleich zu einer subkutanen immuntherapie und zur symptomatischen medikamentösen behandlung bei kindern mit asthma bronchiale, rhinokonjunktivitis und atopischer dermatitis

Allergologie

Volumn 19, Issue 12, 1996, Pages 580-592

  Zwacka, G ^a   Glaser, S ^a   Rieger, B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000762837     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Almugro E., O. Asensio, J.M. Bartolomè, M Bisque, B. de la Hoz. J. Dolz. J. Horza, M. Ferreiro, J.M. Garcia, E. Losada, I. Luna et al: Muticenter Studie zur Arzneimittelsicherheit der sublingualen Immuntherapie bei allergischen Patienten. Allergol et Immunopathol. 4, 153-159 (1995).
2. Andrè C: Sublinguale Immunotherapy. XVI ECACI 1995 Madrid (Vortrag 29 Juni 1995) (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995. ECACI 1995 Madrid).
3. Aznar Igeu J.M., M Lazuro Sastre, S. Quirce Gancedo: Immunotherapia sublingual y oral. Rev. Esp. Alergol Immunol. Clin 9, 3-13 (1994).
4. Borte M.: IgG Subklassendefekte. Klinische Relevanz bei Kindern mit rezidivierenden Infektionen des Respirationstraktes. Jahrbuch der Kinderheilkunde 1995, 101-109
5. Bousquet J : Specific Immunotherapie: New Perspectives. XVI ECACI 1995 Madrid (Vortrag 29. Juni 1995) (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995, ECACI 1995 Madrid).
6. Bruijnzeel-Koomen C.A.F.M., M.J. Fokkens, G.C. Mudde, P.L.B. Bruijnzeel: Role of Langerhans cells in atopic disease. Regulatory processes in allergy and asthma. Int. Arch. Allergy Appl. Immunol. 90, 51-56 (1989).
7. Canonica G.W., C Pronzato, N. Ftorino, G. Cipprandi, M. Bagnasco. Adhesion molecules - a review of their clinical roles in allergic inflammation. Allergy u. Clinical Immunology News 5, 80-84 (1993).
8. Casanovas M., F. Guerra, C. Moreno, R. Miguel, F. Maranòn. J.C. Daza: Double-blind, placebo-controlled clinical trial of preseasonal treatment with allergenic extracts of Olea europaea pollen administrered sublingualy. J. Invest. Allergol. Clin Immunol. 4, 305-315 (1994).
9. Casanovas M., F. Guerra, R. Miguel, C Moreno, J.C. Daza, F. Maranòn: Immunotherapy in olea pollen sublingual extract Double blind study. XVI ECACI 1995 Madrid, P. 0833 (XVI European Congress of Allergology and Clinical Immunology, 25 - 30. Juni 1995, ECACI 1995 Madrid).
10. Clavel R., P. Couturier, D. Basset, G. Fayolle, F Barnier, P. Coulet, M. Grosclaude, J.C. Severae, Y. Terrel, P. Coste, C Grimaud, G. Terrane, M. Terol, F. Masviel, J. Bousquet, C. Andre: Reduction of corticosteroid therapy by sublingual immunotherapy. Double blind study against placebo of a standardized 5 grass pollen extract in rhinitis. XVI ECACI 1995 Madrid, P. 0589 (XVI European Congress of Allergology and Clinical Immunology, 25. -30. Juni 1995, ECACI 1995 Madrid).
11. Cooper P.J., D. Darbyshire, A.J. Nunn, J.O. Warner: A controlled trial of oral hyposensitization in pollen asthma and rhinitis in children. Clin. Allergy 14, 541-550 (1984).
12. Creticos, P.S., R.M. Nacleria, J F. Adkinson, P.S. Norman. Efficacy, safety and kindetics of oral ragweed immunotherapy in the treatment of allergic seasonal rhinitis. J Allergy Clin. Immunol 85, 214-217 (1990).
13. Creticos P.S.: A review of oral immunotherapy with polles extracts. XVI ECACI 1995 Madrid (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995, ECACI 1995 Madrid).
14. Fehziani V., G. Lattuada, S. Parmiani, P.P. Dall'Aglio: Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol. et Immunopath. 21, 173-178 (1993).
15. Giovune A., M. Bardare, G. Possalracqua et al : A three years double blind placebo controlled study with specific oral immunotherapy to Dermatophagoides. Clin. Exp. Allergy 24, 53-59 (1994).
16. Gozalo F., C. Cortès: High clinical efficacy and tolerance in a two years loliuin perenne (LP) sublingual immunotherapy (SLIT) follow-up study. XVI ECACI 1995 Madrid. P. 0829 (XVI European Congress of Allergology and Clinical Immunology. 25. - 30. Juni 1995, ECACI 1995 Madrid).
17. Guadagni G., I. Archinucci, G. Goniglio, V. Akpan, M. Lodovici: The efficacy of sublingual hyposensibilizing therapy. XVI ECACI 1995 Madrid, P. 0828 (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995. ECACI 1995 Madrid)
18. Guerra F , C. Moreno, J.C. Daza, R. Miguel, G. Sanchez, V Peralta, J.F. Florido. P. Gonzalez. B. Saenz de San Pedro. J.F. Crespo, F. Maranòn, M Casanovas: A multicenter study of sublingual wite and subcutaneous immunotherapy with a standardized Olea europaea pollen extract XVI ECACI 1995 Madrid, P. 0832 (XVI European Congress of Allergology and Clinical Immunology. 25. -30. Juni 1995. ECACI 1995 Madrid).
19. Guerra F., M.D. Luque, C. Moreno, J.C. Daza, A. Arenas, P. Sanchez-Guijo. Immunotherapy for olea pollen. 4 years monitoring of allergoid vs. B.U. retard extract. XVI ECACI 1995 Madrid, P 0593 (XVI European Congress of Allergology and Clinical Immunology. 25. - 30. Juni 1995, ECACI 1995 Madrid).
20. Horak F., S. Jäger, U. Berger, B. Marks, A. Temmel, J. Toth: Sublingual verabreichter Birkenpollenextrakt zu Immuntherapie (SLIT). Alk-ABELLÖ. Scientific contribution. XVI ECACI 1995 Madrid (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995, ECACI 1995 Madrid).
21. Jorde W., H.F. Linskens. Zur Persorption von Pollen und Sporen durch die intakte Darmschleimhaut Acta Allerg. 29, 165-175 (1974).
22. Jorde W., P. Linsenmann, K. Werdermann, H.G. Bohlmann: Quantitative Untersuchungen zur enteralen Resorption inhalativer Allergene. Immunitatsforschung Suppl. Bd. 2. Gustav Fischer. Stuttgart 1977.
23. Jorde W: Hyposensibilisierung in der Praxis. HNO 43. 741-744 (1995).
24. Koch R.: Die sublinguale Immuntherapie - eine sinnvolle Alternative zur bekannten subkutanen Immuntherapie? Der Deutsche Dermatologe 3, 321-322 (1993).
25. Lin L.M., C.G. Mac Pherson: Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J. Exp. Med. 177, 1299-1305 (1993).
26. Longo G., F. Poli, S. Saletta, C.M. Salvatore: Oral house-dust mite immunotherapy (ITS) in asthmatic children. XVI ECACI 1995 Madrid, P. 0591 (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995, ECACI 1995 Madrid).
27. Malling H.J.: Perspectives of the EAACI position paper. XVI ECACI 1995 Madrid (Vortrag 29. Juni 1995) (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995, ECACI 1995 Madrid).
28. Mastrandrea F., M. Minellt, N. Rossi, C. Lamanna, A. Tursi: Study about the result of sublingual SLIT in a consecutive series of 35 atopic eczema cuseses. XVI ECACI 1995 Madrid, P. 0590 (XVI European Congress of Allergology and Clinical Immunology, 25. -30. Juni 1995, ECACI 1995 Madrid).
29. Milazzo F., P. Bernardis, M. Agnoleno: Sublinguale contra Injektions-Immuntherapic bei Alternaria-tenius-Allergikern. Allergy Clinical Immunology News, Suppl. Nr. 2, 174 (1992).
30. Mollet C., S. Dreberg, A. Lanner. B. Bjorksten: Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double-blind study. Allergy 41, 271-279 (1986).
31. Mosbech H., S. Droberg, F. Madsen, H. Ohlsson, P. Stahl Shov, E. Taudorf, B. Weeke: High dose grass pollentablets used for hyposensitization in hay fever patients - a one-year double-blind placebo controlled study. Allergy 42, 451-455 (1987).
32. van Niekerk C H., J.S. de Wet: Efficacy of grass/maizepollen oral immunotherapy in patients with saisonal hay fever: a double-blind study. Clin. Allergy 17, 507-513 (1987).
33. Ongari S., P. Domeneghetti, S. Parnuani: Comparison among drugs, injective immunotherapie and sublingual immunotherapy in grass allergic patients XVI ECACI 1995 Madrid, P. 0830 (XVI European Congress of Allergology and Clinical Immunology, 25. - 30 Juni 1995. ECACI 1995 Madrid).
34. Paelez A., C Morales, E. Burches, J. Garde, M.C. Morales, A. Sastre, J. Mesequer, T. Malek, J.F. Crespo, F. Maranon, M. Casanovas: A multicenter study of sublingual route and subcutaneous immunotherapy with a standardized Parietaria judaica pollen extrakt. XVI ECACI 1995 Madrid. P. 0831 (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995, ECACI 1995 Madrid).
35. Passalacqua G., G. W. Canonica: Oral routes for immunotherapy with mites. XVI ECACI 1995 Madrid. Abstracts (S. 1033-1038) (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995, ECACI 1995 Madrid).
36. Piazza J., N. Bizzaro: Humoral response to subcutaneous, oral and nasal immunotherapy for allergic rhinitis due to Der. pier. Ann Allergy 71, 461-469 (1993).
37. Pozzan M , P. Bernards, M. Agnolette: Sublinguale contra Injektions-Immuntherapie bei Alternaria-tenius-Allergikern. Allergy Clinical Immunology News, Suppl. Nr. 2, 174 (1992)
38. Rebien W., U. Wahn, E. Patronen et al.: Vergleichende Studie zur immunologischen und klinischen Wirksamkeit der nasalen und subkutanen Hyposensibilisierung. Allergologie 3, 101-106 (1980).
39. Riccardi L., A. Mussara, S. Isola, E. Savi, P. Puccinelle, F Parello. D. Ambrosia: Rush sublingual immunotherapy in Parietana allergic patients. XVI ECACI 1995 Madrid, P. 0587 (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995. ECACI 1995 Madrid).
40. Ring J.: Nicht Licht, sondern Pollen provozieren das atopische Ekzem. Ärztliche Allgemeine 5, 28-29 (1994).
41. Roossien F.F.: Therapeutische Wirksamkeit allergenhaltiger Lösungen. Hausarzt, Fortbildungsdienst III, F8-F12 (1991).
42. Sabbah A , S. Hassoun, J. Le Selling, C. Anre, H. Sicard: A double-blind, placebo-controlled trial by the sublingual route of immunotherapie with a standardized grass pollen extract (Fa. Stallergene). Allergy 49, 309-313 (1994).
43. Saia B., C. Martin, R. Bizzotto et al.: Preseasonal local nasal immunotherapy with macronized grass pollen powder. Allergologia, 9-14 (1989).
44. Sanchez P.A., F. Schamann Medina, A. Lamas Rua-Figueroa et al.: Comparative clinical-immunologica study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma. Allergol. Immunopathol. 17, 323-329 (1989).
45. Scadding K.G., J Brostoff: Low dose sublingual therapy in patients with allergic rhinitis due to dust mite. Clin. Allergy 16, 483-491 (1986).
46. Tari M.G., M. Mancino, G. Pozzuoli, A. Verga, G. Monti: Immunotherapy with alginate-conjugated two grass pollen extract in patients with allergic rhinoconjunctivitis. Allergol. Immunopath. 18, 35-39 (1989)
47. Tari M.G., M. Mancino, G. Monn. Die Wirksamkeit der sublingualen Immuntherapie bei Patienten mit Rhinitis und Asthma durch Hausstaubmilben Eine Doppeblind-Studie. Allergol. et Immunopathol. 18, 277-284 (1990).
48. Taudorf E., L.C. Laursen, R. Djurup, E. Kappelgaard, C T. Pedersen et al.: Oral administration of grass pollen to hay fever patients. An effiacy study in oral hyposensitization Allergy 40, 321-325 (1985).
49. Taudorf E., L.C. Laursen, A.G. Lanner, B. Bjorkstein, S. Dreborg, M. Soeborg, B. Weeke: Oral immunotherapy in tisch pollen hay fever. J. Allergy Clin Immunol. 80, 153-156 (1987).
50. della Torre E., L. Cassani, G. Piazza, C Ricciotti: Immunotherapy in grass pollen allergy Three kinds of administration. XVI ECACI 1995 Madrid, P. 0827 (XVI European Congress of Allergology and Clinical Immunology, 25. - 30. Juni 1995, ECACI 1995 Madrid).
51. Trotse C., S. Voltolini, A. Canersa, A.C. Negrini. Nasale Sensibilität gegen Parietaria-Pollen wahrend einer dreijährigen sublingualen Immuntherapie. X.V. ICACI Kongress Stockholm, 26.06. - 0107.1994. Allergy/Clinical Immunology News, Suppl. 2. 123 (1994).
52. Urbanek R., R Gehl: Wirksamkeit oraler Hyposensibilisierung bei Hausstaubmilbenallergie. Monatszeitschrift Kinderheilkunde 130, 150-153 (1982).
53. Uibanek R., W. Kuhn, U. Binder. Efficacy of oral and parenteral hyposensitation with pollen extracts. DMW 23, 1433-1437 (1983).
54. Wilmsen van E.J.G., I.M.W. van Hoogstraten, J. Bevè, R.J. Scheper, G. Kraal: Dentritic cells of the oral mucosa and the induction of oral tolerance. A local affair, E.J.G. van Wilmsen, Department of Cell Biology, Vrije Universiteit, Amsterdam 1994.
55. Zwacka G., S Glaser, B. Rieger: Therapeutische Erfahrungen mit einer sublingualen Immuntherapie mit Pangramin SLIT im Vergleich zu einer subkutanen Immuntherapie und zur symptomatischen medikamentösen Behandlung bei Kindern mit Asthma bronchiale. Rhinokonjunktivitis und atopischer Dermatitis (im Druck).